CAMP4 Therapeutics Corporation Common Stock (CAMP) Stock Price

CAMPStock
$4.45+178.71%52W
Market Cap$279.25M
P/E
PEG Ratio
Div yield
Beta-24.92

CAMP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-3.52%
Price vs S&P 500 (4W)23.26%
VGM Score49.15

CAMP Earnings Surprise History

Q2 25-0.62est. -0.67
Q3 25-0.54est. -0.48
Q4 25-0.23est. -0.29
Q1 26-0.21est. -0.21
Q2 26-0.22est. -0.21

CAMP Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.25
4.25
4.31
4.31

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
CAMPCAMP4 Therapeutics Corporation Common Stock
CC$4.45
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About CAMP4 Therapeutics Corporation Common Stock

Camp4 Therapeutics is a clinical-stage biopharmaceutical company developing RNA-based therapeutics to restore protein levels in genetic diseases of the central nervous system and liver. The company's pipeline includes two lead programs, CMP-CPS-001 and CMP-SYNGAP.